Stevard LLC’s Exact Sciences EXAS Stock Holding History

Stevard LLC’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,597	Closed	-$265K	–	99
2020 Q3	$265K	Buy	+2,597	New	+$224K	0.11%	124

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Stevard LLC's EXAS Position: Q4 2020 in Review

Stevard LLC sold out of Exact Sciences (EXAS) in Q4 2020, closing a stake of 2,597 shares — an estimated $265K sold.

Stevard LLC first reported a position in EXAS in Q3 2020 and held it in 1 quarter. The position peaked at $265K in Q3 2020. 621 funds tracked by Wall St. Rank hold EXAS as of Q4 2020.

Stevard LLC reported no remaining Exact Sciences position as of Q4 2020 after selling out during the quarter.
Stevard LLC sold 2,597 Exact Sciences shares in Q4 2020, an estimated $265K.
Stevard LLC first reported a position in Exact Sciences in Q3 2020 and held it in 1 quarter.
Stevard LLC's Exact Sciences position peaked at $265K in Q3 2020.
621 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2020.

Based on Stevard LLC's 13F filing for Q4 2020, filed 12 Feb 2021.